The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.
Proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Awards, Young Investigator Awards, and Pilot Awards. Special opportunities are also available in immunotherapy, radiation oncology, metastatic uveal melanoma, and patient-centric melanoma clinical trials. We intend to support at least $11.5 million in new funding through this RFP.
URL for more information:
Full descriptions of each award opportunity offered, including all Special Opportunities, as well as eligibility criteria and instructions can be found on the MRA website at CureMelanoma.org/RFP
Please note the following key deadlines:
|•||October 5: Letters of Intent Due for RTFCCR-MRA Team Science Awards on Patient-Centered Clinical Trials|
|•||October 19: Young Investigator Award Eligibility Checklist Due|
|•||November 2: Full Proposals Due|
All proposals are due by 11:59 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/.
Filed Under: Funding Opportunities